• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童生长激素治疗:挑战、机遇与考量

Childhood growth hormone treatment: challenges, opportunities, and considerations.

作者信息

Tidblad Anders, Sävendahl Lars

机构信息

Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden; Division of Paediatric Endocrinology, Karolinska University Hospital, Stockholm, Sweden.

Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden; Division of Paediatric Endocrinology, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Lancet Child Adolesc Health. 2024 Aug;8(8):600-610. doi: 10.1016/S2352-4642(24)00127-5. Epub 2024 Jun 27.

DOI:10.1016/S2352-4642(24)00127-5
PMID:38945136
Abstract

With long standing demand and popularity, growth hormone treatments continue to be a topic of interest for paediatric endocrinologists and general paediatricians due to ongoing issues regarding their long-term effects, the safety of childhood treatment, and the introduction of long-acting growth hormone preparations in the past decade. Moreover, uncertainty regarding how to approach individual patients and their treatment indications remains, particularly concerning tailored treatment goals and objectives; this uncertainty is further complicated by the multitude of approved indications that surpass substitution therapy. The paediatric endocrinologist thus grapples with pertinent questions, such as what defines reasonable treatment goals for each individual given their indications, and when (and how) to initiate the necessary discussions about risks and benefits with patients and their families. The aim of this Review is to offer advanced physiological concepts of growth hormone function, map out approved paediatric indications for treatment along with evidence on their effects and safety, highlight controversies and complexities surrounding childhood growth hormone treatment, and discuss the potential of long-acting growth hormone and future directions in the realm of childhood growth hormone treatment.

摘要

由于生长激素治疗长期存在需求且广受欢迎,加之其长期影响、儿童期治疗安全性以及过去十年长效生长激素制剂的引入等持续存在的问题,该治疗仍然是儿科内分泌学家和普通儿科医生感兴趣的话题。此外,对于如何治疗个体患者及其治疗指征仍存在不确定性,尤其是在定制治疗目标方面;众多已批准的适应症超越了替代疗法,这使得这种不确定性更加复杂。因此,儿科内分泌学家面临着一些相关问题,比如根据每个患者的指征,什么才是合理的治疗目标,以及何时(以及如何)与患者及其家属就风险和益处展开必要的讨论。本综述的目的是提供生长激素功能的先进生理学概念,梳理已批准的儿科治疗适应症及其疗效和安全性证据,突出儿童生长激素治疗周围的争议和复杂性,并讨论长效生长激素的潜力以及儿童生长激素治疗领域的未来发展方向。

相似文献

1
Childhood growth hormone treatment: challenges, opportunities, and considerations.儿童生长激素治疗:挑战、机遇与考量
Lancet Child Adolesc Health. 2024 Aug;8(8):600-610. doi: 10.1016/S2352-4642(24)00127-5. Epub 2024 Jun 27.
2
Growth hormone therapy in children; research and practice - A review.儿童生长激素治疗:研究与实践——综述
Growth Horm IGF Res. 2019 Feb;44:20-32. doi: 10.1016/j.ghir.2018.12.004. Epub 2018 Dec 26.
3
The Treatment of Growth Disorders in Childhood and Adolescence.儿童及青少年生长障碍的治疗
Dtsch Arztebl Int. 2024 Feb 9;121(3):96-106. doi: 10.3238/arztebl.m2023.0247.
4
Long-acting growth hormone in the management of GHD in France.长效生长激素在法国生长激素缺乏症治疗中的应用。
Arch Pediatr. 2024 Aug;31(6):357-364. doi: 10.1016/j.arcped.2024.03.009. Epub 2024 Jul 18.
5
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.美国临床内分泌医师协会和美国内分泌学会成人生长激素缺乏症管理指南以及儿科向成人保健过渡患者的指南。
Endocr Pract. 2019 Nov;25(11):1191-1232. doi: 10.4158/GL-2019-0405.
6
Long-Acting Growth Hormone Preparations - Current Status and Future Considerations.长效生长激素制剂 - 当前现状与未来考量。
J Clin Endocrinol Metab. 2020 Jun 1;105(6):e2121-33. doi: 10.1210/clinem/dgz149.
7
Hormone replacement therapy in children: The use of growth hormone and IGF-I.儿童激素替代疗法:生长激素和 IGF-I 的应用。
Best Pract Res Clin Endocrinol Metab. 2015 Jun;29(3):339-52. doi: 10.1016/j.beem.2015.04.009. Epub 2015 Apr 29.
8
Efficacy and safety of long-acting growth hormone in children with short stature: a systematic review and meta-analysis.长效生长激素治疗身材矮小儿童的疗效和安全性:系统评价和荟萃分析。
Endocrine. 2019 Jul;65(1):25-34. doi: 10.1007/s12020-019-01950-9. Epub 2019 May 22.
9
Idiopathic short stature: decision making in growth hormone use.特发性身材矮小:生长激素使用的决策。
Indian J Pediatr. 2012 Feb;79(2):238-43. doi: 10.1007/s12098-011-0607-6. Epub 2011 Nov 19.
10
Emerging options in growth hormone therapy: an update.生长激素治疗的新选择:最新进展
Drug Des Devel Ther. 2011;5:411-9. doi: 10.2147/DDDT.S23140. Epub 2011 Aug 30.

引用本文的文献

1
Recombinant growth hormone improves growth and adult height: a comparison between treated and untreated patients with idiopathic growth hormone deficiency.重组生长激素可改善生长情况及成人身高:特发性生长激素缺乏症治疗组与未治疗组患者的比较
Transl Pediatr. 2025 Mar 31;14(3):442-451. doi: 10.21037/tp-2024-576. Epub 2025 Mar 26.
2
Predictive Factors of Persistent Growth Hormone Deficiency and Impact on Final Height.持续性生长激素缺乏的预测因素及其对终身高的影响。
Children (Basel). 2025 Mar 3;12(3):324. doi: 10.3390/children12030324.